Core Viewpoint - Humanoid robots are emerging as a significant focus in the tech industry, with expectations of mass production and increased market presence by 2026, particularly highlighted at the CES event [4][5][6]. Group 1: Industry Developments - The 2026 CES will showcase numerous humanoid robots, with major companies like Boston Dynamics and Qualcomm presenting their latest innovations [4][5]. - The humanoid robot market is expected to see substantial growth, with Tesla projected to produce between 50,000 to 100,000 units by 2026, marking the beginning of a phase of mass production and commercial exploration [8]. Group 2: Market Potential - The humanoid robot market is forecasted to reach a size of $5 trillion by 2050, with an estimated deployment of 1 billion units, suggesting a potential ownership rate of one humanoid robot per ten people [8]. - A significant number of companies are entering the humanoid robot sector through mergers, fundraising, and strategic collaborations, indicating a rapid acceleration in industry investment and commercialization [7]. Group 3: Investment Opportunities - There are 31 humanoid robot concept stocks predicted to have a net profit growth rate exceeding 20% in both 2026 and 2027, indicating strong investment potential [10]. - Five stocks, including Zhimi Intelligent and Softcom Power, show an upside potential of over 30% based on the latest closing prices compared to target prices set by analysts [11].

Group 1: Humanoid Robots Industry - Humanoid robots are emerging as one of the most promising frontier fields, attracting attention from global tech giants and investors [2] - The 2026 CES will showcase a significant number of humanoid robots, with companies like Boston Dynamics and others presenting their latest advancements [7] - The market for humanoid robots is expected to grow substantially, with projections indicating a market size of $5 trillion by 2050 and a deployment of 1 billion units [10] Group 2: Market Trends and Developments - The storage chip sector saw a notable rise, with companies like Liyuan Co., Chang Aluminum, and others hitting their daily price limits [3] - A significant price increase for DRAM is anticipated, with Samsung and SK Hynix proposing a 60%-70% price hike for the first quarter of 2026 compared to Q4 2025 [6] - The humanoid robot production year is approaching, with several companies announcing plans for mass production and strategic collaborations to enhance their capabilities [9] Group 3: Investment Opportunities - There are 31 humanoid robot concept stocks predicted to have a net profit growth rate exceeding 20% in 2026 and 2027 [11] - Five stocks, including Zhiwei Intelligent and Softcom Power, show an upside potential of over 30% based on the latest closing prices compared to target prices [12] - Zhiwei Intelligent leads with a projected upside of 46.17%, focusing on embodied intelligence and various robotic applications [12]

Group 1 - Humanoid robots are emerging as a highly promising frontier in technology, attracting attention from global tech giants and investors [1] - The 2026 CES will showcase a significant number of humanoid robots, with companies like Boston Dynamics and others presenting their latest advancements [2] - The CEO of Creative Strategies highlighted that the CES will feature a surge in humanoid robots, particularly from China, indicating a robust ecosystem [2] Group 2 - Hyundai Motor Group announced that Boston Dynamics will showcase a mass-produced version of the Atlas humanoid robot at CES 2026, aiming to integrate it into their global network for practical tasks [3] - The humanoid robot industry is entering a mass production phase, with several companies expected to achieve production milestones by 2025 and 2026 [4] - Tesla is projected to produce between 50,000 to 100,000 humanoid robots by 2026, marking the industry’s transition into a phase of mass production and commercial exploration [4] Group 3 - A significant number of A-share market stocks are positioned within the humanoid robot industry, with 31 stocks expected to see net profit growth exceeding 20% in 2026 and 2027 [5] - Stocks such as Zhimi Intelligent and Softcom Power are identified as having substantial upside potential, with predicted price increases exceeding 30% [5] - Zhimi Intelligent leads with a projected upside of 46.17%, focusing on embodied intelligence and various robotic applications [5][6] Group 4 - The rolling P/E ratio for Huqin Technology is noted to be the lowest at 24.3 times, with expectations of continued revenue growth in AI and server sectors [6] - The report indicates that the humanoid robot market is expected to reach a size of $5 trillion by 2050, with a deployment of 1 billion units, suggesting a significant market opportunity [4]

相关报告：智研咨询发布的《2026-2032年中国通信设备行业市场行情监测及发展趋向研判报告》 上市公司：中国长城（000066），浪潮信息（000977），新大陆（000997），魅视科技（001229），智 微智能（001339），纳思达（002180），证通电子（002197），大华股份（002236），电科网安 （002268），中威电子（300270），智迪科技（301503），中润光学（688307），萤石网络 （688475），三未信安（688489） 根据国家统计局数据可知：2025年11月全国计算机、通信和其他电子设备制造业出口货值为5693.1亿 元，同比下降4%；2025年1-11月全国计算机、通信和其他电子设备制造业累计出口货值为57402.2亿 元，累计同比增长0.5%。 2019年-2025年1-11月全国计算机、通信和其他电子设备制造业出口货值统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场 ...

格隆汇1月5日丨智微智能(001339.SZ)公布，近年来，具身智能正经历从"任务专一型"向"通用具身智 能"的范式转移，具身智能大模型不仅有望成为突破传统机器人控制瓶颈的核心路径，更是响应国家战 略与社会需求的重要技术方向。为抢先布局具身智能大模型，提升核心竞争力，充分把握具身智能产业 发展机遇，公司与瓴真私募基金管理（嘉兴）有限公司（简称"瓴真私募"）等合作方共同签署了《共青 城楷联恒真创业投资合伙企业（有限合伙）合伙协议》，由公司与沈建强、旷怡、张菁菁和魏宇强共同 对共青城楷联恒真进行增资，通过直接或间接的方式对星源智进行投资。本次增资后，共青城楷联恒真 认缴规模拟从2,240万元增至人民币3,320万元，公司作为有限合伙人拟以自有资金认缴出资人民币500万 元，占合伙企业15.06%份额。 ...

格隆汇1月5日丨智微智能(001339.SZ)公布，近年来，具身智能正经历从"任务专一型"向"通用具身智 能"的范式转移，具身智能大模型不仅有望成为突破传统机器人控制瓶颈的核心路径，更是响应国家战 略与社会需求的重要技术方向。为抢先布局具身智能大模型，提升核心竞争力，充分把握具身智能产业 发展机遇，公司与瓴真私募基金管理（嘉兴）有限公司（简称"瓴真私募"）等合作方共同签署了《共青 城楷联恒真创业投资合伙企业（有限合伙）合伙协议》，由公司与沈建强、旷怡、张菁菁和魏宇强共同 对共青城楷联恒真进行增资，通过直接或间接的方式对星源智进行投资。本次增资后，共青城楷联恒真 认缴规模拟从2,240万元增至人民币3,320万元，公司作为有限合伙人拟以自有资金认缴出资人民币500万 元，占合伙企业15.06%份额。 ...

证券代码：001339 证券简称：智微智能 公告编号：2026-001 深圳市智微智能科技股份有限公司 关于与专业投资机构共同投资的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 1、深圳市智微智能科技股份有限公司（以下简称 "公司"）作为有限合伙人， 拟以自有资金向共青城楷联恒真创业投资合伙企业（有限合伙）（以下简称"共 青城楷联恒真"）认缴出资人民币 500 万元。 2、共青城楷联恒真投资方向为单一投资标的，即以直接或间接的方式投资 于北京星源智机器人科技有限公司（以下简称"星源智"），存在单一投资标的风 险；且具有投资周期较长、流动性较低的特点，投资效益存在不确定性等风险。 3、根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律 监管指引第 7 号——交易与关联交易》及《公司章程》等相关规定，本次共同投 资无需提交公司董事会、股东会审议，不构成同业竞争和关联交易，亦不构成《上 市公司重大资产重组管理办法》规定的重大资产重组。 根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管 指引第 7 号——交易与关联 ...

南财智讯1月4日电，智微智能公告，公司近日收到控股股东、实际控制人郭旭辉先生和袁微微女士出具 的《关于减持公司股份变动比例触及1%整数倍的告知函》。2025年12月17日至12月30日期间，郭旭辉 通过集中竞价交易减持公司股份53万股，通过大宗交易减持公司股份256.7万股，累计减持公司股份 309.7万股。本次权益变动后，郭旭辉与袁微微合计持有公司股份1.70935亿股，占公司总股本比例为 67.76%。本次权益变动不会导致公司控制权发生变更，也不会对公司的治理结构、股权结构及未来持 续经营产生重大影响。本次减持计划仍在实施中，尚未全部完成。 ...

证券代码：001339 证券简称：智微智能 公告编号：2025-091 深圳市智微智能科技股份有限公司 关于控股股东、实际控制人权益变动触及1%整数倍的公告 公司近日收到控股股东、实际控制人郭旭辉先生和袁微微女士出具的《关于减 持公司股份变动比例触及 1%整数倍的告知函》，获悉在 2025 年 12 月 17 日至 2025 年 12 月 30 日期间，郭旭辉先生通过集中竞价交易减持公司股份 530,000 股，通过大 宗交易减持公司股份 2,567,000 股，累计减持公司股份 3,097,000 股。本次权益变动 后，公司控股股东、实际控制人郭旭辉先生和袁微微女士合计持有公司股份 170,935,000 股，占公司总股本比例为 67.76%，变动触及 1%的整数倍。现将有关情 况公告如下： 1．基本情况 信息披露义务人一 郭旭辉 本公司控股股东、实际控制人郭旭辉先生和袁微微女士保证向本公司提供的信息内容 真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 持计划范围内。截至本公告日，本次减持计划尚未全部 实施完毕。 本次变动是否存在违反《证券 法》《上市公司收购管理办 法》等法律、行政法规、部 门规章 ...

Core Viewpoint - A total of 65 stocks in the A-share market experienced block trading today, with a total transaction value of 1.12 billion yuan, indicating active trading activity in the market [1] Group 1: Trading Activity - The top three stocks by transaction value were Jinfakeji (1.12 billion yuan), Zhiwei Intelligent (71.23 million yuan), and Changying Precision (63.91 million yuan) [1] - Among the stocks traded, 4 were at par value, 1 at a premium, and 60 at a discount; Muyuan Foods had a premium rate of 0.61% [1] - The highest discount rates were observed in Xiangming Intelligent (22.13%), Tianyin Electromechanical (21.64%), and Shenxinfeng (21.22%) [1] Group 2: Institutional Trading - The top buying amounts from institutional special seats were led by Zhiwei Intelligent (36.18 million yuan), Baosheng Co. (28.99 million yuan), and Bai'ao Chemical (13.52 million yuan) [1] - The top selling amounts from institutional special seats included Senqilin (10.59 million yuan) and Kangtai Biological (7.33 million yuan) [1]